NCT07470996
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
694 public trials
105 recruiting studies
Lymphoma, T-Cell trial results
NCT07414758
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT06630091
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT04848064
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT07389616
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
NCT05296304
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activites) Rockville Centre, New York, United States
NCT04390737
- Conditions
- Advanced Solid Tumor, Epithelioid Sarcoma, FL Lymphoma, +15 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
- NEXT Oncology San Antonio, Texas, United States
Recruiting
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
NCT06909877
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sichuan Cancer Hospital Chengdu, China
NCT04670874
- Conditions
- Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT06069830
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China